Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025GlobeNewsWire • 02/18/25
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)GlobeNewsWire • 01/10/25
BDSX Stock Rises After Publication of Study Data for Nodify CDT TestZacks Investment Research • 01/08/25
Biodesix Announces Publication of a New Nodify CDT® Clinical Validation StudyGlobeNewsWire • 01/07/25
Biodesix (BDSX) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 11/20/24
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical StudyBusiness Wire • 10/07/24
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual MeetingBusiness Wire • 05/21/24
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule ManagementBusiness Wire • 05/08/24
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual MeetingBusiness Wire • 04/09/24